(Q39549282)

13 September 2017

title

Imaging prostate cancer lymph node metastases with a multimodality contrast agent (English)

1 reference

13 September 2017

0 references

1 reference

1 reference

9

Eva M Sevick-Muraca

1 reference

13 September 2017

Mary A Hall

1

1 reference

13 September 2017

Sunkuk Kwon

2

1 reference

13 September 2017

Holly Robinson

3

1 reference

13 September 2017

Pier-Anne Lachance

4

1 reference

13 September 2017

Ali Azhdarinia

5

1 reference

13 September 2017

Ranjani Ranganathan

6

1 reference

13 September 2017

Roger E Price

7

1 reference

13 September 2017

Wenyaw Chan

8

1 reference

13 September 2017

language of work or name

1 reference

2 May 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

72

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

129-146

1 reference

Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Pelvic lymph node dissection in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

18F-labeled BBN-RGD heterodimer for prostate cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Positron emission tomography imaging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

A low molecular weight PSMA-based fluorescent imaging agent for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

EpCAM (CD326) finding its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Preclinical assessment of an anti-EpCAM immunotoxin: locoregional delivery provides a safer alternative to systemic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Identification of EpCAM as a molecular target of prostate cancer stroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Position Emission Tomography Imaging Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

The presence of prostate cancer on saturation biopsy can be accurately predicted.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Significance of micrometastases in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

PET/CT Imaging and Radioimmunotherapy of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

American Cancer Society guideline for the early detection of prostate cancer: update 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

USE OF TWO EPITHELIUM-SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSIS OF MALIGNANCY IN SEROUS EFFUSIONS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21413

21 January 2018

Identifiers

DOI

10.1002/PROS.21413

1 reference

13 September 2017

1 reference